Securing a stable supply of Hepalyse ingredients and expanding the consumer healthcare business through the conversion of 日水製薬医薬品販売 into a subsidiary

An M&A theme involving the acquisition of 日水製薬医薬品販売 as a wholly owned subsidiary to secure a stable supply of the main ingredient for Hepalyse and expand the consumer healthcare business. Following the acquisition, the company changed its name to 健創製薬.